{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:14:00Z","timestamp":1648656840650},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T00:00:00Z","timestamp":1206748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1208\/s12249-008-9067-3","type":"journal-article","created":{"date-parts":[[2008,3,28]],"date-time":"2008-03-28T19:56:59Z","timestamp":1206734219000},"page":"639-645","source":"Crossref","is-referenced-by-count":3,"title":["Preformulation Considerations for Controlled Release Dosage Forms: Part II\u2014Selected Candidate Support"],"prefix":"10.1208","volume":"9","author":[{"given":"Frank","family":"Chrzanowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,29]]},"reference":[{"key":"9067_CR1","unstructured":"K. Ahmed. The Preparation and Physical-Chemical Characterization of Linogliride Salts for Controlled Release, MS Thesis, Univ Cincinnati, 1987."},{"key":"9067_CR2","first-page":"10","volume":"32","author":"W. D. Walkling","year":"1986","unstructured":"W. D. Walkling, W. R. Sisco, M. P. Newton, B. J. Fegely, and F. A. Chrzanowski. Stability of fenretinide polymorphs. Acta. Pharm. Technol.\n                  32:10\u201312 (1986).","journal-title":"Acta. Pharm. Technol."},{"key":"9067_CR3","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/jps.2600731032","volume":"73","author":"F. A. Chrzanowski","year":"1984","unstructured":"F. A. Chrzanowski, B. J. Fegely, W. R. Sisco, and M. P. Newton. Analysis of N-(4-hydroxyphenyl)retinamide polymorphic forms by X-ray powder diffraction. J. Pharm. Sci.\n                  73:1448\u20131450 (1984).","journal-title":"J. Pharm. Sci."},{"key":"9067_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3109\/03639048109057733","volume":"7","author":"H. H. El-Shattawy","year":"1981","unstructured":"H. H. El-Shattawy, G. E. Peck, and D. O. Kildsig. Aspartame-direct compression excipients: preformulation stability screening using differential scanning calorimetry. Drug Dev. Ind. Pharm.\n                  7:605\u2013619 (1981).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"9067_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3109\/03639048209022136","volume":"8","author":"H. H. El-Shattawy","year":"1982","unstructured":"H. H. El-Shattawy, D. O. Kildsig, and G. E. Peck. Erythromycin-direct compression excipients: preformulation stability screening using differential scanning calorimetry. Drug Dev. Ind. Pharm.\n                  8:937\u2013947 (1982).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"9067_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3109\/03639048609048037","volume":"12","author":"F. A. Chrzanowski","year":"1986","unstructured":"F. A. Chrzanowski, L. A. Ulissi, B. J. Fegely, and A. C. Newman. Preformulation excipient compatibility testing. Application of a differential scanning calorimetric method versus a wet granulation simulating isothermal stress method. Drug Dev. Ind. Pharm.\n                  12:783\u2013800 (1986).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"9067_CR7","unstructured":"H.-U. Heese, H. Junger, A. Laicher, C. Lorck, T. Profitlich, and G. Weiss. US Patent No. 7,276,253; Stable drug for the oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof, Oct 2, 2007."},{"key":"9067_CR8","unstructured":"Prevacid\u00ae lansoprazole package insert No. 03-5530-R25, TAP Pharmaceuticals Inc., Lake Forrest IL, Rev Sept 2006."},{"key":"9067_CR9","unstructured":"T. Makino, T. Tabata, and S. Hirai. Canadian Patent No. 1,327,010; Stabilized solid pharmaceutical compositions containing antiulcer benzimidazole compound and its production, Feb 12, 1987."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9067-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-008-9067-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9067-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9067-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:48:10Z","timestamp":1559620090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-008-9067-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,29]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9067"],"URL":"https:\/\/doi.org\/10.1208\/s12249-008-9067-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,29]]}}}